痛泻要方治疗溃疡性结肠炎的作用机制研究进展
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

湖南省自然科学基金青年项目(2020JJ5425);湖南省教育厅优秀青年项目(19B424)


Research Progress on Mechanism of Tongxieyao Formula in the Treatment of Ulcerative Colitis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    痛泻要方(TXYF)是治疗痛泻的经典名方,近年来在溃疡性结肠炎(UC)的治疗中效果显著,基础研究逐渐从微观角度探讨了其治疗UC的作用机制。国内外学者对TXYF治疗UC药理作用机制进行了较为系统的研究,初步阐明了该方治疗UC的作用机制。本文检索近年来TXYF治疗UC的相关文献,从调节免疫功能、修复肠黏膜屏障、调节胃肠平滑肌、调控细胞凋亡过程等方面进行综述,以期为后期研究提供新思路。

    Abstract:

    Tongxieyao Formula is a classic prescription for the treatment of pain diarrhea.It has achieved remarkable effect in the treatment of ulcerative colitis(UC) in recent years.Basic research has gradually explored its mechanism of action in the treatment of UC from a microscopic perspective.The pharmacological mechanism of TXYF in the treatment of UC has been systematically studied by domestic and foreign scholars,and the mechanism of action of TXYF in the treatment of UC has been preliminarily elucidated.In this paper,relevant literature on the treatment of UC by TXYF in recent years were reviewed from the aspects of regulating immune function,repairing intestinal mucosal barrier,regulating gastrointestinal smooth muscle,and regulating the process of apoptosis,etc.in order to provide new ideas for further research.

    参考文献
    相似文献
    引证文献
引用本文

张婷,施敏,廖陈敏,刘富林.痛泻要方治疗溃疡性结肠炎的作用机制研究进展[J].世界中医药,2021,(10).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-01-07
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-06-24
  • 出版日期:
文章二维码